The first stop for professional medicines advice

Transporting COVID-19 Vaccine Pfizer-BioNTech from Designated Sites to end user location

Tracy Rogers, Director, Medicines Use & Safety, Medicines Use and Safety TeamPublished Last updated See all updates
Topics: Pfizer-BioNTech Vaccine: Handling in PCNsStandard Operating Procedures

Standard Operating Procedure for transporting COVID-19 Vaccine Pfizer-BioNTech from designated sites to end user locations.

Information

A standard operating procedure is attached to this page.

You should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations before using this SOP.

The core principles in the SOPs are common and may be adapted for use and sign off in all care settings.

They may be adapted by Superintendent Pharmacists for the use of the vaccine in Community Pharmacy settings.

 

Attachments

Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

SPS and COVID-19 Vaccination programme
We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
Get in touch
If you're a healthcare professional in England, get in touch with us if you still have questions

Change history

  1. New section on Mutual Aid added. Clarification that returning vials to stock is not normal practice.
  1. Link to NHSE position statement added to section 4.4
  1. PVH7 - Amendment of content and scope to include requirements for use of Regulation 174 and licensed Comirnaty products. Removal of waste code table. Addition to clarify wholesaler responsibility regarding transit time greater than 6 hours to delivery. Addition to include storage in suitably calibrated fridge at end user site. Addition of statement regarding immediate use. New section added on transport of diluted Comirnaty vaccine and associated risks.
  1. 120 hours changed to 31 days.
  1. PCN removed from title, clarification box added as terminology has changed. Additional point added that stock cannot be returned to the fridge after transport.
  1. Addition of wording to webpage referring to use within Community Pharmacy settings.
  1. Published